Society


Posts filtered by tags: Astrazeneca[x]


 

UK’s Covid vaccine programme on track despite AstraZeneca problems

Seventy-five per cent of population can be fully immunised by first week in August, according to forecastsCoronavirus – latest updatesSee all our coronavirus coverageThe UK’s vaccination programme is expected to be effectively completed shortly after the United States’ this summer, and several weeks ahead of the EU, despite falling up to six weeks behind because of problems affecting its workhorse AstraZeneca jab.Airfinity, which tracks vaccination programmes worldwide, forecasts that 75% of the...
Tags: Vaccines and immunisation, Health, Society, Coronavirus, Infectious diseases, World news, US news, Medical research, Microbiology, Science


UK ministers silent on AstraZeneca vaccine shipment to Australia

Downing Street will not confirm or deny report that more than 700,000 Covid jabs were sent after EU blocked exportCoronavirus – latest updatesSee all our coronavirus coverageBritish ministers and officials did not deny that more than 700,000 shots of the AstraZeneca vaccine were secretly dispatched from the UK to Australia a few weeks ago as the EU blocked the drug’s export.The Sydney Morning Herald reported that 717,000 AstraZeneca doses were dispatched in late February and March from the compa...
Tags: Health, Europe, Business, Politics, UK, Australia, Eu, European Union, Society, UK News, World news, Australia news, Public services policy, European Commission, Health policy, Astrazeneca


Vaccine confidence fears as under-30s in UK offered AstraZeneca alternative

Experts warn of impact after advice changes in response to 79 blood clot cases out of 20m vaccinationsJab fears may play into hands of anti-vaxxersCoronavirus – latest UK updatesSee all our coronavirus coverageExperts warned of damage to confidence in the UK’s vaccine programme after 10 million adults under 30 were told they will be offered an alternative to the Oxford/AstraZeneca jab following concerns over rare blood clots.Healthy 18- to 29-year-olds who are not at high risk of Covid should ha...
Tags: Health, UK, Science, Society, UK News, World news, Medical Research, Infectious Diseases, Astrazeneca, Vaccines and immunisation, JCVI, Coronavirus, Oxford AstraZeneca


AstraZeneca Covid vaccine: weighing up the risks and rewards

Despite scientific advice to continue getting the jab, answers about fatal blood clots are urgently neededCoronavirus – latest updatesSee all our coronavirus coverageVaccines have side-effects, as do all medicines. Most often, jabs cause sore arms, a headache or a bit of nausea – none of which would be very significant when weighed against the toll of a serious virus such as Covid-19.But sometimes the risk-benefit calculation may look less simple, as in the case of Oxford/AstraZeneca’s Covid jab...
Tags: Health, Europe, UK, Society, UK News, Medical Research, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Coronavirus, Oxford AstraZeneca


EU drug agency denies already finding causal link between AstraZeneca vaccine and blood clots

European Medicines Agency says review ongoing after head of vaccines spoke of ‘clear’ associationCoronavirus – latest updatesSee all our coronavirus coverageEurope’s drug regulator has denied it has already established a causal connection between the Oxford/AstraZeneca vaccine and a rare blood clotting syndrome, after a senior official from the agency said there was a link.In a statement to Agence France-Presse, the European Medicines Agency (EMA) said on Tuesday it had “not yet reached a conclu...
Tags: Health, Europe, Eu, European Union, Society, Infectious Diseases, Astrazeneca, Vaccines and immunisation, European Medicines Agency, Coronavirus, Oxford AstraZeneca


Covid: seven deaths reported in Oxford/AstraZeneca UK recipients

Experts say numbers of rare blood clots remain low and benefits of vaccine far outweigh risks of Covid-19 infectionCoronavirus – latest updatesSee all our coronavirus coverageFurther cases of a rare blood clotting syndrome and seven deaths have been reported among recipients of the Oxford/AstraZeneca jab in the UK, although experts say the numbers remain low and the benefits of the vaccine far outweigh any risks.The Medicines and Healthcare products Regulatory Agency (MHRA), runs a “yellow card”...
Tags: Health, UK, Society, UK News, World news, Oxford, Astrazeneca, Vaccines and immunisation, Regulatory Agency MHRA, Medicines and Healthcare, Coronavirus, Oxford AstraZeneca


Experts stress vaccine benefits outweigh risks after seven UK deaths

30 reported cases of blood-clotting issues after AstraZeneca Covid-19 jab out of 18m dosesCoronavirus – latest updatesSee all our coronavirus coverageFurther cases of a rare blood clotting syndrome including seven deaths have been reported among recipients of the Oxford/AstraZeneca jab in the UK, although experts say the numbers remain low and the benefits of the vaccine far outweigh any risks.The Medicines and Healthcare products Regulatory Agency (MHRA), runs a “yellow card” scheme to pick up ...
Tags: Health, UK, Society, UK News, World news, Astrazeneca, Vaccines and immunisation, Regulatory Agency MHRA, Medicines and Healthcare, Coronavirus, AstraZeneca COVID, Oxford AstraZeneca


Seven UK recipients of Oxford jab reported dead after clotting

Experts say numbers of rare blood clots remain low and benefits of Covid vaccine far outweigh risksCoronavirus – latest updatesSee all our coronavirus coverageFurther cases of a rare blood clotting syndrome including seven deaths have been reported among recipients of the Oxford/AstraZeneca jab in the UK, although experts say the numbers remain low and the benefits of the vaccine far outweigh any risks.The Medicines and Healthcare products Regulatory Agency (MHRA), runs a “yellow card” scheme to...
Tags: Health, UK, Society, UK News, World news, Oxford, Astrazeneca, Vaccines and immunisation, Regulatory Agency MHRA, Medicines and Healthcare, Coronavirus, Oxford AstraZeneca


Coronavirus live news: England passes 25m first vaccine dose milestone; Brazil daily deaths near 4,000 amid surge

Vaccines minister says first booster doses will go to the top four priority groups, which includes care home staff, NHS workers and clinically extremely vulnerableOne in 25 hospitalised with Covid in UK since December had vaccine‘Vaccine prince’: the Indian billionaire set to make Covid jabs for the UKGazebo sales boom as families plan outdoor Easter gatheringsSee all our coronavirus coverage 3.31pm GMT A woman in New York lost her personal injury lawsuit after her attorney refused to wear a...
Tags: Health, UK, England, New York, Indonesia, India, Society, World news, Brooklyn, NHS, Brazil, Who, Astrazeneca, Vaccines and immunisation, New York Daily News, Reuters India


'Vaccine prince': the Indian billionaire set to make Covid jabs for the UK

Serum Institute boss Adar Poonawalla has rented a Mayfair mansion for £50,000 a weekCoronavirus – latest updatesSee all our coronavirus coverageThe AstraZeneca vaccine has made Prof Sarah Gilbert – who led the Oxford team that created it – one of the UK’s most famous modern scientists and turned the Anglo-Swedish pharmaceutical company into a household name.But almost half of all the AstraZeneca shots, destined for the arms of hundreds of millions of people around the world, are being produced b...
Tags: Health, Business, UK, India, Society, UK News, World news, South and Central Asia, Oxford, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Mayfair, Sarah Gilbert, Serum Institute, Adar Poonawalla


UK moves to ease tensions with EU over Covid vaccine exports

Sources raise possibility of sharing jab supplies from Dutch AstraZeneca plant as diplomacy blitz beginsCoronavirus – latest updatesSee all our coronavirus coverageMinisters will seek to calm tensions over a potential EU ban on vaccine exports to the UK in a diplomacy blitz this week as sources raised the possibility of sharing jab supplies from a Dutch plant.Sources said the UK government was keen to offer support and expertise at the AstraZeneca vaccine production plant in the Netherlands, run...
Tags: Health, Europe, Politics, UK, Eu, European Union, Society, UK News, Foreign Policy, Netherlands, Health policy, Astrazeneca, Coronavirus, Halix


Vaccine wars: the week that rocked the UK’s Covid jab rollout

After a week of bans, U-turns and warnings of supply shortfalls, public confidence in vaccination has been dented. Can Britain get back on the fast track out of lockdown? Coronavirus – latest updatesSee all our coronavirus coverageFor Stacey Harris, the hardest part of organising vaccinations over the last couple of months has been fending off patients. “They’d be ringing up, coming into the surgery saying ‘I want my vaccine,’” she told the Observer.But last week that popularity evaporated. On T...
Tags: Health, Europe, Politics, UK, France, European Union, Society, World news, Britain, Infectious Diseases, Astrazeneca, Pharmaceuticals industry, Boris Johnson, Vaccines and immunisation, Kent, HARRIS


France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously

Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effectiveCoronavirus – latest updatesSee all our coronavirus coverageFrance has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved judgment until next week, a day after Europe’s health regulator declared the shot safe and effective for all age groups.As politicians launched an urgent effort to convince citizens of the vaccine’s safet...
Tags: Health, Europe, Sweden, France, Eu, Society, World news, Infectious Diseases, Astrazeneca, Denmark, Pharmaceuticals industry, Vaccines and immunisation, Norway, EMA, Coronavirus, AstraZeneca COVID


Europe still uneasy about AstraZeneca Covid jab despite EMA green light

France restricts vaccine to over-55s as Norway, Sweden and Denmark reserve judgment on its useCoronavirus – latest updatesSee all our coronavirus coverageFrance has said only people aged 55 and over should receive the Oxford/AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved judgment until next week, a day after Europe’s health regulator declared the shot to be safe and effective for all age groups.As politicians launched an urgent effort to convince citizens of the vac...
Tags: Health, Europe, Sweden, France, Society, World news, Infectious Diseases, Oxford, Astrazeneca, Denmark, Pharmaceuticals industry, Vaccines and immunisation, Norway, Norway Sweden, Coronavirus


France limits AstraZeneca Covid jab to over-55s despite EMA green light

Norway, Sweden and Denmark reserve judgment until next week on resuming use of vaccineCoronavirus – latest updatesSee all our coronavirus coverageFrance has said only people aged 55 and over should receive the Oxford/AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved judgment until next week, a day after Europe’s health regulator declared the shot to be safe and effective for all age groups.As politicians launched an urgent effort to convince citizens of the vaccine’s s...
Tags: Health, Europe, Sweden, France, Society, World news, Infectious Diseases, Oxford, Astrazeneca, Denmark, Pharmaceuticals industry, Vaccines and immunisation, Norway, Norway Sweden, Coronavirus


European countries to resume AstraZeneca jabs after safety backing

EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorderCoronavirus – latest updatesSee all our coronavirus coverageItaly, France and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines regulator said the vaccine was “safe and effective” and its benefits outweighed its risks.Germany and Portugal will resume on Monday, Spain and the Netherlands next week, while Sweden’s public health age...
Tags: Health, Europe, Sweden, France, Germany, Spain, Society, World news, Italy, Netherlands, Portugal, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, EMA, Coronavirus


AstraZeneca Covid vaccine is safe and effective, says European regulator

EMA says benefits outweigh risks but also that it is continuing to study possible link with very rare blood clotting disorderCoronavirus – latest updatesSee all our coronavirus coverageThe AstraZeneca coronavirus vaccine is “safe and effective” and its benefits outweigh the risks, Europe’s medicines regulator has said, but it would continue to study possible links between the shot and a very rare blood clotting disorder.The director of the European Medicines Agency (EMA), Emer Cooke, said the ag...
Tags: Health, Europe, Science, Biology, Society, World news, Medical Research, Infectious Diseases, Microbiology, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, EMA, Coronavirus, European Medicines Agency EMA Emer Cooke


EU medicines regulator to report on AstraZeneca Covid vaccine safety

Medicines agency under pressure to clear up blood clot concerns and take brakes off Europe’s vaccination driveCoronavirus – latest updatesSee all our coronavirus coverageEurope’s medicines regulator is under mounting pressure to clear up safety concerns over the Oxford/AstraZeneca Covid vaccine as experts warned that arguably political decisions to pause it in many countries risked seriously delaying the continent’s already sluggish vaccination drive.The European Medicines Agency (EMA) is due on...
Tags: Health, Europe, Eu, European Union, Society, World news, Oxford, Astrazeneca, Vaccines and immunisation, European Medicines Agency EMA, Coronavirus


AstraZeneca jab: EU regulator 'firmly convinced' benefits outweigh risks

Agency says there are ‘no indications’ the vaccine causes blood clots, but the risk may be higher for some groupsCoronavirus – latest updatesSee all our coronavirus coverageThe EU’s medicines regulator has said it remains “firmly convinced” the benefits of the Oxford/AstraZeneca Covid vaccine outweigh the risks, but isolated cases of blood clots “are a serious concern and need serious and detailed scientific evaluation”.Emer Cooke, the head of the European Medicines Agency (EMA), said there was ...
Tags: Health, Europe, Science, Eu, Society, World news, Oxford, World Health Organization, Astrazeneca, Vaccines and immunisation, European Medicines Agency EMA, Emer Cooke, Coronavirus


Ireland suspends AstraZeneca Covid vaccine over blood clot concerns

Deployment of Oxford vaccine temporarily deferred after latest reports from NorwayCoronavirus – latest updatesSee all our coronavirus coverageIreland is suspending use of the Oxford/AstraZeneca vaccine against Covid as a precautionary measure following further reports of blood clots in people who have received it, this time from Norway.The deputy chief medical officer, Dr Ronan Glynn, said Ireland’s advisory body on vaccines had recommended that deployment of the AstraZeneca jab should be “tempo...
Tags: Health, Europe, Business, Science, Biology, Society, World news, Medical Research, Ireland, Infectious Diseases, Microbiology, Oxford, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Norway


Several EU countries suspend AstraZeneca vaccine to investigate blood clot cases

European Medicines Agency say ‘benefits outweigh its risks’ and vaccine can continue to be used Coronavirus – latest updatesSee all our coronavirus coverageThe European Medicines Agency has said the Oxford/AstraZeneca Covid vaccine can continue to be used during an investigation into cases of blood clots that have prompted several European countries to pause their use of the shot.The EMA said 30 cases of “thromboembolic events” or blood clots had been reported among 5 million people who had rece...
Tags: Health, Europe, Eu, Society, World news, Austria, Italy, Oxford, Astrazeneca, Denmark, Pharmaceuticals industry, Vaccines and immunisation, Norway, Iceland, European Medicines Agency, EMA


EMA says AstraZeneca vaccine can continue to be used during investigation

Several countries suspend inoculations but regulator says vaccine benefits outweigh its risks Coronavirus – latest updatesSee all our coronavirus coverageThe European Medicines Agency has said the Oxford/AstraZeneca Covid vaccine can continue to be used during an investigation into cases of blood clots that have prompted several European countries to pause their use of the shot.The EMA said 30 cases of “thromboembolic events” or blood clots had been reported among 5 million people who had receiv...
Tags: Health, Europe, Society, World news, Austria, Italy, Oxford, Astrazeneca, Denmark, Pharmaceuticals industry, Vaccines and immunisation, Norway, Iceland, European Medicines Agency, EMA, Coronavirus


In France, there's no escape from Covid vaccine sceptics. What would Pasteur think?

As the rumour and disinformation mills go into overdrive, GPs are having to drum up patients to use up their allocation of jabsThere’s a joke doing the rounds in France: how do you get a Frenchman to have the Covid vaccine? Tell him he can’t have it.My dentist – who is French – recounted this and found it hilarious. My doctor – who is not French – was not so amused. Like other GPs she has been trying, and not always succeeding, to persuade her patients to have the AstraZeneca jab. Yes, you read ...
Tags: Health, Europe, France, Social Media, Society, World news, Astrazeneca, Vaccines and immunisation, Immunology, Coronavirus, COVID


From Pfizer to Moderna: who's making billions from Covid-19 vaccines?

The companies in line for the biggest gains – and the shareholders who have already made fortunesCoronavirus – latest updatesSee all our coronavirus coverageThe arrival of Covid-19 vaccines promises a return to more normal life – and has created a global market worth tens of billions of dollars in annual sales for some pharmaceutical companies.Among the biggest winners will be Moderna and Pfizer – two very different US pharma firms which are both charging more than $30 per person for the protect...
Tags: Health, Business, Science, US, Society, World news, Stock Markets, Medical Research, Infectious Diseases, Microbiology, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Pfizer, Moderna, Coronavirus


From Pfizer to Moderna: who's making billions from Covid vaccines?

The companies in line for the biggest gains – and the shareholders who have already made fortunesCoronavirus – latest updatesSee all our coronavirus coverageThe arrival of Covid-19 vaccines promises a return to more normal life – and has created a global market worth tens of billions of dollars in annual sales for some pharmaceutical companies.Among the biggest winners will be Moderna and Pfizer – two very different US pharma firms which are both charging more than $30 per person for the protect...
Tags: Health, Business, Science, US, Society, World news, Stock Markets, Medical Research, Infectious Diseases, Microbiology, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Pfizer, Moderna, Coronavirus


Coronavirus vaccine strategy needs rethink after resistant variants emerge, say scientists

Oxford vaccine shown to have only limited effect against South African variant of coronavirusCoronavirus – latest updatesSee all our coronavirus coverageLeading vaccine scientists are calling for a rethink of the goals of vaccination programmes, saying that herd immunity through vaccination is unlikely to be possible because of the emergence of variants like that in South Africa.The comments came as the University of Oxford and AstraZeneca acknowledged that their vaccine will not protect people ...
Tags: Health, UK, Africa, Society, World news, South Africa, Oxford, Astrazeneca, Vaccines and immunisation, University of Oxford, Coronavirus


Vaccine strategy needs rethink after resistant variants emerge, say scientists

Goal should be protecting at-risk groups not herd immunity, say experts, after Oxford vaccine shown not to work fully against variantsCoronavirus – latest updatesSee all our coronavirus coverageLeading vaccine scientists are calling for a rethink of the goals of vaccination programmes, warning that herd immunity through vaccination is unlikely to be possible because of the emergence of variants like that in South Africa.The comments came as the University of Oxford and AstraZeneca acknowledged t...
Tags: Health, UK, Africa, Society, World news, South Africa, Oxford, Astrazeneca, Vaccines and immunisation, University of Oxford, Coronavirus, Oxford AZ


Community vaccinator: ‘It can be very frustrating, but we feel like we‘re injecting hope‘

A community worker talks anonymously about the challenges and rewards of delivering the Covid jabCoronavirus – latest updatesSee all our coronavirus coverageAt the end of November, when the hospital I was working at was becoming overwhelmed with Covid patients, I started hearing talk about people being needed to join the vaccine effort. I usually work elsewhere in the NHS, but my work had been stopped temporarily. I now work as a vaccinator in the community going to care homes and assisted-livin...
Tags: Health, Society, UK News, Britain, Infectious Diseases, NHS, Astrazeneca, Vaccines and immunisation, Coronavirus


Oxford Covid vaccine almost as effective against Kent variant, trials suggest

Scientists say it offers only slightly lower protection compared with original CovidCoronavirus – latest updatesSee all our coronavirus coverageThe Covid vaccine developed by the University of Oxford and AstraZeneca is nearly as effective against the Kent variant as it is against older forms of the virus, according to preliminary research results.Researchers analysed swabs from trial volunteers who developed asymptomatic or symptomatic infections to determine which variant of the virus they had ...
Tags: Health, Science, Society, UK News, Medical Research, Infectious Diseases, Astrazeneca, Pharmaceuticals industry, University of Oxford, Coronavirus


The Guardian view on the vaccine rollout: the state we're in | Editorial

Making mistakes, as Boris Johnson and the EU have discovered, is a precondition for ongoing successBritain’s Covid-19 vaccine success contains an important lesson for the rest of the world: a pandemic is no place for the rigid application of free-market principles. Boris Johnson has got many things wrong in the past year, but his decision to mobilise the Keynesian state has saved lives. Faced with deadly coronavirus, Mr Johnson followed in the slipstream of the US to fund, develop and produce va...
Tags: Health, Europe, Politics, UK, US, Eu, European Union, Society, Medical Research, NHS, Health policy, Astrazeneca, Boris Johnson, Vaccines and immunisation, Johnson, Coronavirus



Filters
show more filters
February - 2021
MoTuWeThFrSaSu
1234567
891011121314
15161718192021
22232425262728
March - 2021
MoTuWeThFrSaSu
1234567
891011121314
15161718192021
22232425262728
293031    
April - 2021
MoTuWeThFrSaSu
   1234
567891011
12131415161718
19202122232425
2627282930